Literature DB >> 8954045

Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum.

A Bereket1, T A Wilson, S L Blethen, J Fan, R A Frost, M C Gelato, C H Lang.   

Abstract

A small portion of circulating insulin-like growth factor I (IGF-I) is detected in the free or readily dissociable state, which is thought to be the metabolically active form. The amount of free/dissociable IGF-I in serum is dependent on a complex interplay between the production rate and the concentrations of IGF-I and IGF-binding proteins (IGFBPs). IGF availability is also influenced by posttranslational changes in IGFBPs that affect the affinity of IGFBPs for IGF-I. In the present study, we examined whether a short term fast (approximately 12 h) alters the serum concentration of free/dissociable IGF-I, and whether these changes are associated with alterations in IGFBP-1 and the proteolysis status of IGFBP-3. Circulating free/dissociable IGF-I concentrations, as assessed by a two-site immunoradiometric assay, did not differ between fasting and 4 h after a morning meal (1.48 +/- 0.07 vs. 1.50 +/- 0.07 microgram/L, respectively). Likewise, free/dissociable IGF-I levels measured by RIA after separation by centrifugal ultrafiltration were not different between the two groups (1.43 +/- 0.14 vs. 1.38 +/- 0.18 microgram/L, respectively). IGF-I bioactivity, as measured by thymidine incorporation by fibroblasts, did not differ in fasting and 4-h postprandial sera. There was no difference in IGFBP-3 and total acid-ethanol-extractable IGF-I concentrations in serum from fasted and fed subjects. In contrast, the concentration of IGFBP-1 in the serum was increased approximately 5-fold in the fasted state compared to fed values. IGFBP-1 existed in a highly phosphorylated form under fasting conditions. There was no change in IGFBP-3 proteolysis assessed either in vivo or in vitro between the fasting and fed states. The results indicate that a physiologically relevant short term overnight fast does not alter the circulating levels of free/dissociable IGF-I despite a marked elevation in IGFBP-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954045     DOI: 10.1210/jcem.81.12.8954045

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.

Authors:  Yin Cao; Katharina Nimptsch; Irene M Shui; Elizabeth A Platz; Kana Wu; Michael N Pollak; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2014-11-10       Impact factor: 7.396

Review 2.  Nutrition and the insulin-like growth factor system.

Authors:  C F Estívariz; T R Ziegler
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

3.  Role of insulin-like growth factor binding proteins in human post-nephrectomy proximal tubule cells.

Authors:  D W Johnson; H J Saunders; M J Field; C A Pollock
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

4.  Effects of Short-term Fasting on Ghrelin/GH/IGF-1 Axis in Healthy Humans: The Role of Ghrelin in the Thrifty Phenotype.

Authors:  Tim Hollstein; Alessio Basolo; Yigit Unlu; Takafumi Ando; Mary Walter; Jonathan Krakoff; Paolo Piaggi
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

5.  Investigating the Relationship Between IGF-I, IGF-II, and IGFBP-3 Concentrations and Later-Life Cognition and Brain Volume.

Authors:  Antoine Salzmann; Sarah-Naomi James; Dylan M Williams; Marcus Richards; Dorina Cadar; Jonathan M Schott; William Coath; Carole H Sudre; Nishi Chaturvedi; Victoria Garfield
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.